Rare Neurological Disease Treatment Market Share

Statistics for the 2023 & 2024 Rare Neurological Disease Treatment market share, created by Mordor Intelligence™ Industry Reports. Rare Neurological Disease Treatment share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Rare Neurological Disease Treatment Industry

The Rare Neurological Disease Treatment Market is moderately consolidated. The market consists of a few significant players that dominate the market, including CSL Ltd, Kedrion Biopharma Inc., US WorldMeds LLC (Solstice Neurosciences LLC), Merz Pharma GmbH & Co. KGaA, Aquestive Therapeutics Inc., Bayer AG, Pfizer Inc., Novartis AG, Merck & Co. Inc. (EMD Serono Inc.), Jazz Pharmaceuticals PLC, F. Hoffmann - La Roche Ltd Biogen Inc, and Teva Pharmaceutical Industries Ltd.

Rare Neurological Disease Treatment Market Leaders

  1. CSL Ltd

  2. Merz Pharma GmbH & Co. KGaA

  3. Kedrion Biopharma Inc.

  4. US WorldMeds LLC (Solstice Neurosciences LLC)

  5. Aquestive Therapeutics Inc.

*Disclaimer: Major Players sorted in no particular order

Rare Neurological Disease Treatment Market.png

Rare Neurological Disease Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)